Core Insights - The Cigna Group reported a 30% increase in total revenues for Q3 2024, reaching $63.7 billion, driven by significant growth in Evernorth Health Services [1][2][18] - Shareholders' net income for Q3 2024 was $0.7 billion, or $2.63 per share, which includes a non-cash after-tax investment loss of $1.0 billion related to VillageMD [1][2][18] - Adjusted income from operations for Q3 2024 was $2.1 billion, or $7.51 per share, reflecting a 5% increase from Q3 2023 [1][2][18] - The company reaffirmed its 2024 outlook for adjusted income from operations of at least $28.40 per share [1][13] Financial Performance - Total revenues for Q3 2024 were $63.7 billion, up from $49.0 billion in Q3 2023 [2][18] - Adjusted revenues for Q3 2024 were $63.7 billion, compared to $49.1 billion in Q3 2023 [2][18] - Shareholders' net income decreased from $1.4 billion in Q3 2023 to $0.7 billion in Q3 2024 [2][18] - Adjusted income from operations increased from $2.0 billion in Q3 2023 to $2.1 billion in Q3 2024 [2][18] Segment Performance - Evernorth Health Services saw adjusted revenues increase by 36% and adjusted income from operations increase by 9% compared to Q3 2023 [7][8] - Pharmacy Benefit Services reported a 50% increase in adjusted revenues, while Specialty and Care Services reported a 23% increase [7][8] - Cigna Healthcare's adjusted revenues increased by 3% year-over-year, while adjusted income from operations decreased by 4% [9][18] Customer Relationships - Total customer relationships increased by 12% from December 31, 2023, to 183.5 million as of September 30, 2024 [4][5] - Total pharmacy customers increased by 22% from December 31, 2023, to 120.0 million [5][4] - Total medical customers were 19.0 million, reflecting a decrease in Individual and Family Plans customers [5][4] Operational Efficiency - The SG&A expense ratio for Q3 2024 was 5.6%, down from 7.7% in Q3 2023, indicating improved operational efficiency [2][18] - The adjusted SG&A expense ratio was 5.5% for Q3 2024, compared to 7.3% in Q3 2023 [2][18] Future Outlook - The Cigna Group projects adjusted income from operations for the full year 2024 to be at least $28.40 per share [1][13] - The company anticipates Evernorth adjusted income from operations to be at least $7,000 million and Cigna Healthcare adjusted income from operations to be at least $4,775 million [13]

The Cigna Group reported a $700 million third quarter profit as the company's Evernorth health ... [+] services business deals with a $1 billion loss in value of its investment in doctor-staffed clinic operator VillageMD. Walgreens Boots Alliance The Cigna Group reported a $739 million third quarter profit despite a $1 billion loss on its investment in clinic operator VillageMD. On Thursday, Cigna reported a "non-cash investment loss" of $1 billion, or $3.69 per share, "related to VillageMD." That negativel ...

There has been speculation of a massive merger in the medical sector between two massive health insurers. Specifically, the rumor is The Cigna Group NYSE: CI is interested in acquiring Humana Inc. NYSE: HUM. The conjecture caused both stocks to react, as Cigna stock fell 10% as the rumored surfaced on Oct. 18, 2024, and Humana stock remained relatively flat. Based on the reactions, the market doesn't see this as a favorable merger, and for good reason. While there are many potential synergies in a merger, a ...

In its upcoming report, Cigna (CI) is predicted by Wall Street analysts to post quarterly earnings of $7.22 per share, reflecting an increase of 6.7% compared to the same period last year. Revenues are forecasted to be $59.84 billion, representing a year-over-year increase of 21.9%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe. Before a com ...

Group 1 - Cigna Group is pursuing a merger with Humana, reigniting discussions that previously failed last year due to price disagreements [2] - Following the news, Cigna's stock fell nearly 5%, significantly more than the S&P 500 index's 0.2% decline [1] - Current discussions between Cigna and Humana are informal and at an early stage, with no decisions made yet, and a potential wait until 2025 for a deal [2] Group 2 - Humana specializes in Medicare Advantage plans, which face challenges from rising medical costs and stricter payment regulations, potentially complementing Cigna's traditional health insurance offerings [3] - Despite the negative initial market reaction, the merger could create significant synergies between the two companies [3]

Key TakeawaysDiscussions over Cigna's possible purchase of Humana reportedly have resumed after the two health insurers failed to strike a deal last year.Bloomberg said the talks are in their early stages.Humana has struggled lately as Medicare changes negatively impact results, while Cigna is selling its Medicare business to HCSC. Humana (HUM) shares edged higher Monday morning on a report that The Cigna Group (CI) has resumed discussions to buy its smaller health insurance rival after negotiations fell ap ...

54 community-based organizations receive funds to support the dietary needs of older adultsBLOOMFIELD, Conn., Oct. 21, 2024 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE: CI), is investing $600,000 in community-based organizations this fall to address food insecurity among older Americans. Collectively, the funds are expected to impact more than 1.4 million people in need."Food insecurity continues to be a major challenge for seniors in our country, and that can con ...

In trading on Friday, shares of The Cigna Group crossed below their 200 day moving average of $340.21, changing hands as low as $338.60 per share. The Cigna Group shares are currently trading off about 3.8% on the day. Start slideshow: 10 Stocks Crossing Below Their 200 Day Moving Average » The chart below shows the one year performance of CI shares, versus its 200 day moving average: CI tickertech Looking at the chart above, CI's low point in its 52 week range is $253.95 per share, with $370.825 as the 52 ...

Industry Overview - The U.S. health insurance industry, known as Health Maintenance Organization (HMO), is poised for growth due to rising premiums and increasing membership, particularly with the aging population driving demand for Medicare [1] - The HMO sector includes entities that provide basic and supplemental health services, assuming risks and assigning premiums to health insurance policies [2] Key Trends - High technology costs are a significant concern as HMOs invest in telehealth services to meet the growing demand for digital healthcare, which may pressure profit margins [3] - A nationwide shortage of medical staff, particularly nurses, is impacting care quality and could affect membership retention for HMOs [4] - Growing premiums are a primary revenue driver, with enhancements to health plans aimed at attracting and retaining members, especially as Medicare demand rises with an aging population [5] - Active mergers and acquisitions (M&A) are being pursued to expand capabilities and diversify, supported by potential interest rate cuts that may facilitate financing for these deals [6] Performance Metrics - The Zacks Medical-HMO industry has underperformed, with a 0.8% decline compared to the S&P 500's 34.4% growth over the past year [8] - The industry trades at a forward 12-month price-to-earnings (P/E) ratio of 15.69X, lower than the S&P 500's 22.09X and the sector's 22.75X [9] Company Highlights - **UnitedHealth Group**: Strong performance driven by its UnitedHealthcare and Optum divisions, with a 2024 earnings estimate of $27.65 per share, reflecting a 10.1% increase from 2023 [11] - **Cigna**: Growth supported by its Evernorth and Cigna Healthcare platforms, with a 2024 earnings estimate of $28.48 per share, indicating 13.5% growth from 2023 [12] - **Humana**: Growth fueled by higher premiums and an expanding customer base, with a 2024 earnings estimate of $16.12 per share [13] - **Molina Healthcare**: Focused on affordable Medicare and Medicaid plans, with a 2024 earnings estimate of $23.50 per share, representing a 12.6% increase from the previous year [14]

Group 1 - The Cigna Group will release its third quarter 2024 financial results on October 31, 2024, at 6:30 a.m. ET [1] - A conference call to discuss the financial results will take place at 8:30 a.m. ET on the same day, with a suggested dial-in time of 8:15 a.m. ET [1] - The conference call will be accessible via a live internet webcast and will be in listen-only mode [1] Group 2 - A copy of the news release and financial supplement will be available on The Cigna Group's website by 6:30 a.m. ET on October 31 [2] - The Cigna Group is a global health company with approximately 186 million customer relationships worldwide [2]